Tag: Regulation/Government Policy

[ad_1] Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of a rare genetic disease. The FDA approved Wainua, which has generic name eplontersen, for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. Ionis said Wainua would be available in the U.S. in January. Regulatory reviews elsewhere in the world are currently underway. The disease, also known as hAATR, can cause polyneuropathy, a form of nerve damage. The companies said Wainua is the only approved medicine for treating polyneuropathy from hATTR. The approval ... Read more

[ad_1] The Federal Deposit Insurance Corporation is fighting back against a lawsuit brought by nearly 170 former employees of First Republic Bank who are seeking to recover retirement funds they had deposited in a trust set up by the failed lender. The FDIC is arguing that the federal court where the lawsuit was filed earlier this month doesn’t have the authority to grant the temporary restraining order the plaintiffs are seeking, and even if it did, the plaintiffs have failed to make a compelling argument that they would eventually… [ad_2] Source link